Status:
COMPLETED
Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group
Lead Sponsor:
University Hospital, Geneva
Conditions:
COVID-19 Pandemic
Vulnerable Subjects
Eligibility:
All Genders
18-100 years
Brief Summary
The Swiss population underwent a period of confinement related to the COVID-19 pandemic (March 16 to May 11, 2020) decided by the Swiss Federal Government. Among the Swiss population, certain groups w...
Detailed Description
The Swiss population underwent a period of confinement related to the COVID-19 pandemic (March 16 to May 11, 2020) decided by the Swiss Federal Government. Among the Swiss population, certain groups w...
Eligibility Criteria
Inclusion
- Patients followed by the Division of Pulmonology of Geneva University Hospitals with home NIV
- Aged above 18 years of age
- Stable clinical condition
Exclusion
- Age below 18 years of age
- Unwillingness to participate
- Unstable clinical condition
Key Trial Info
Start Date :
June 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04477473
Start Date
June 30 2020
End Date
August 31 2020
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre antituberculeux; Geneva University Hospital
Geneva, Geneva 14, Switzerland, 1211